Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?

J Thromb Haemost. 2019 Aug;17(8):1401-1403. doi: 10.1111/jth.14547.

Authors

Bernard Tardy¹, Andrea Buchmuller¹, Ingrid M Bistervels², Fionnuala Ni Ainle³, Saskia Middeldorp²

Affiliations

¹ Inserm CIC 1408, FCRIN-INNOVTE, CHU de Saint Etienne, Saint Etienne, France.
² Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
³ Department of Haematology, Mater Misericordiae University Hospital and Rotunda Hospital, Dublin, Ireland.

PMID: 31368223
DOI: 10.1111/jth.14547

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Enoxaparin
Female
Heparin, Low-Molecular-Weight
Humans
Pregnancy
Pregnancy Complications, Cardiovascular*
Venous Thromboembolism*

Substances

Anticoagulants
Enoxaparin
Heparin, Low-Molecular-Weight